RBC Capital initiates Gildan Activewear stock with Outperform rating

RBC Capital initiated coverage on Gildan Activewear (GIL) with an Outperform rating and a $61 price target, citing the company's strong execution, product innovation driving market share gains, and manufacturing expansion for cost efficiencies. This positive outlook is reinforced by Gildan's healthy financial position, consistent dividends, and aggressive share buybacks. The apparel manufacturer recently reported robust second-quarter earnings, exceeding consensus estimates, which has prompted other firms like CFRA, Barclays, and Scotiabank to also raise their price targets, highlighting Gildan's high margins, strong return on invested capital, and advantageous supply chain.

Analysis

Gildan Activewear (GIL) is experiencing a wave of positive analyst sentiment, led by RBC Capital's initiation of coverage with an Outperform rating and a $61.00 price target. This bullish outlook is underpinned by several key factors: strong operational execution, product innovation driving market share gains, and a strategic manufacturing expansion in Bangladesh expected to yield significant cost efficiencies. The company's financial health appears robust, evidenced by a strong Q2 earnings report where normalized EPS reached $0.97, up from $0.74 year-over-year, and revenue grew to $919 million, surpassing consensus estimates. This performance has been further validated by other firms, including Barclays and Scotiabank, which have raised their price targets to $56.00 and $55.00 respectively, citing high margins, strong return on invested capital, and efficient free cash flow conversion. The company's commitment to shareholder returns, through consistent dividends and aggressive share buybacks, combined with a 30.57% stock price increase over the past year, reinforces the narrative of a well-managed firm successfully navigating industry challenges through a low-cost structure and advantageous supply chain.

Key Decisions for Investors

• Given the broad analyst consensus and strong Q2 results beating estimates, investors could consider the stock favorably, as its strategy of operational efficiency and capital returns appears to be delivering value.
• Monitor future earnings releases for evidence of margin expansion stemming from the Bangladesh facility and for data confirming continued market share capture, as these are the core pillars of the current bull thesis.
• Despite the positive outlook, investors should note the stock's significant 30.57% appreciation over the past year and consider the range of analyst price targets ($55-$61) to evaluate the potential upside from current levels, acknowledging CFRA's more cautious 'Hold' rating as a point of contrast.